Recognising that the protection of cancer patients through immunisation against COVID-19 is a public health priority, ESMO is launching today a Call to Action on the topic of ‘COVID-19 vaccinations and patients with cancer’.
As healthcare professionals and patient advocacy organisations representing cancer patients and their families, our aim is to work together to ensure that the first principle of the WHO’s value framework for the allocation and prioritisation of immunisation is adhered to: to reduce deaths and disease burden and protect those who most need protection.
The ESMO Call to Action will be launched during a virtual meeting today where leading experts from the World Health Organization, the European Commission, the European Medicines Agency, and the cancer patient community will present and discuss strategies on the impact and importance of COVID-19 vaccinations in patients with a high-risk profile, including those with cancer.